CLINICAL_TRIALS
trial_result
· 2011-09-29
Clinical Trial Update: SITELINE 2 Polyurethane [Phase 3]
Summary
Boston Scientific's SITELINE 2 Polyurethane Phase 3 trial for Bradycardia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Bradycardia | Phase 3 | Status: COMPLETED